Module 3: Secondary Prevention
Secondary prevention strategies for patients with established ASCVD.
Secondary Prevention: Atherosclerotic Cardiovascular Disease Risk Assessment
For patients WITH established atherosclerotic cardiovascular disease. Complete the form below to determine risk stratification and guideline-directed therapy.
Atherosclerotic Cardiovascular Disease Event History
Select all prior major atherosclerotic cardiovascular disease events
Current Lipid-Lowering Therapy
Enter current LDL Cholesterol level and medications
Additional High-Risk Conditions
Check all conditions that apply. These influence risk stratification (high vs very high).
IMPORTANT: This software is clinical decision support (CDS) intended for use by licensed healthcare professionals under Section 520(o)(1)(E) of the Federal Food, Drug, and Cosmetic Act. It is not intended as a medical device. All recommendations are derived from the 2026 ACC/AHA Guideline on the Management of Dyslipidemia and must be independently verified by the treating clinician before any clinical action. AI-generated content (including extracted data and clinical notes) is produced by large language models and may contain errors, omissions, or hallucinations — clinician review is mandatory. Patient data entered into the calculator is processed entirely in the browser; AI features process data server-side under a signed HIPAA Business Associate Agreement with no data retention. AI-HEART Lab, its affiliates, and contributors assume no liability for clinical decisions made using this tool. By using this tool, you acknowledge these limitations and accept full responsibility for clinical decisions.